Serum Ceruloplasmin/Albumin ratio in HIV patients with anti retroviral therapy

Journal Title: Medpulse International Journal of Biochemistry - Year 2018, Vol 8, Issue 1

Abstract

Background: HIV is a life long illness and requires regular monitoring and treatment as per the clinical, immunological and viral status of HIV patients. The various simple cost effective prognostic markers need to be examined as substitute to CD4 and viral load. Serum Ceruloplasmin/Albumin ratio has already proved its significance in monitoring of progression and treatment in various inflammatory diseases like tuberculosis. Objective: To estimate serum Ceruloplasmin /Albumin ratio in HIV patients with antiretroviral therapy. Material and Methods: It is a case control study. The study was conducted on 50 clinically diagnosed patients of HIV attending Centre of Excellence of HIV AIDS Sir JJ Group of Hospitals Mumbai. Fifty HIV seronegative age and sex matched subjects were taken as controls. Venous blood about 5 ml was collected and serum ceruloplasmin and serum albumin were measured on autoanalyser. Results: A statistically significant increased value of Ceruloplasmin /Albumin ratio was noted in HIV patients as compared to control (p<0.001). Conclusion: Our study may be evident of Ceruloplasmin/ Albumin ratio increase in HIV patients on ART. Further study of this ratio with different stages of HIV may assist in monitoring prognosis and treatment of HIV patients on antiretroviral therapy.

Authors and Affiliations

H M Deshmukh, R V Bhivapure, V W Patil, V S Nagar

Keywords

Related Articles

Estrogen, progesterone receptors and breast cancer - an evaluative and correlative study

Background: Breast cancer is the second most common cause of cancer death worldwide. Estrogen and progesterone are the major hormones involved in regulation of breast tumor growth. The role of hormone receptors as a prog...

Enzymatic and non-enzymatic antioxidants changes in precancerous and cancerous lesions of oral cavity

Background: Involvement of ROS in the development of tobacco related oral carcinogens is speculated. Little is known about the status of ROS scavengers or antioxidant enzymes in association with precancerous and cancerou...

Glycated hemoglobin in diagnosis of diabetes mellitus: Descriptive clinical study

Background: Type 1 and type 2 are the two broad categories of diabetes mellitus. Insulin deficiency as a result of autoimmune immunodeficiency leads to Type 1 Diabetes. Type 2 diabetes mellitus is a heterogeneous group o...

Duration of type 2 diabetes mellitus as a threat indicator for the microalbuminuria; A signal for diabetic nephropathy

Background: Diabetes mellitus is one of the major health problem leading to the long term kidney damage and responsible for 30-40% of all chronic kidney diseases. Aim and Objectives: The study was conducted to find the a...

Role of 25 hydroxy Vitamin-D in parkinson’s disease

Abstract Problem statement: Parkinson disease is the second most prevalent neurodegenerative disease worldwide. In the initial stage of the disease, the most obvious symptoms are movement related, which include tremors,...

Download PDF file
  • EP ID EP442130
  • DOI 10.26611/1002813
  • Views 159
  • Downloads 0

How To Cite

H M Deshmukh, R V Bhivapure, V W Patil, V S Nagar (2018). Serum Ceruloplasmin/Albumin ratio in HIV patients with anti retroviral therapy. Medpulse International Journal of Biochemistry, 8(1), 11-13. https://www.europub.co.uk/articles/-A-442130